Daphne Karydas Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daphne Karydas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daphne Karydas. Daphne Karydas is a Chief Financial Officer in Syndax Pharmaceuticals Inc ($SNDX) and a Director in LogicBio Therapeutics, Inc. ($LOGC).
Address: 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM 02451 MA
Companies in which Daphne Karydas is an Insider
LogicBio Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Daphne Karydas: Director
Holdings: 0 shares
Latest Transaction: Dec 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daphne Karydas: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 05 2021
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Daphne Karydas
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Karydas Daphne | Chief Financial Off ... | Option Exercise | A | 21.36 | 95,000 | 2,029,200 | 95,000 | |
| Dec 14 2020 | LOGC | LogicBio Therapeut ... | Karydas Daphne | Director | Option Exercise | A | 7.36 | 20,000 | 147,200 | 20,000 | |
| Dec 14 2020 | LOGC | LogicBio Therapeut ... | Karydas Daphne | Director | Option Exercise | A | 7.36 | 20,000 | 147,200 | 20,000 |